Keyword Analysis & Research: pharmacodynamics of insulin glargine

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
pharmacodynamics of insulin glargine	1.47	0.3	2822	75	36
pharmacodynamics	0.33	0.2	2509	17	16
of	1.81	0.6	259	61	2
insulin	0.79	0.1	3342	28	7
glargine	1.84	0.7	8164	13	8

Keyword	CPC	PCC	Volume	Score
pharmacodynamics of insulin glargine	0.19	0.9	2254	66
pharm class of insulin glargine	1.3	0.9	3727	45
mechanism of action of insulin glargine	0.93	0.2	5827	69
insulin glargine pharmacological class	1.86	1	6396	62
insulin glargine type of insulin	1.95	1	5787	92
glargine and regular insulin	0.42	0.7	3256	65
glargine type of insulin	1.34	0.7	1560	57
glargine long acting insulin	1.43	1	9945	75
glargine insulin length of action	0.3	0.9	3815	28
insulin glargine classification of drug	1.41	0.4	4039	10
insulin glargine drug study	0.89	1	2890	29
insulin glargine 2 units	0.46	0.7	616	58
insulin glargine therapeutic effect	1.13	0.2	9043	10
glargine insulin long or short acting	1.66	0.7	907	49
insulin glargine molecular weight	1.33	0.9	6075	42
what is glargine insulin	2	0.2	920	39

Pharmacokinetics and pharmacodynamics of insulin glargine
nih.gov

https://pubmed.ncbi.nlm.nih.gov/27453980/

DA: 26 PA: 27 MOZ Rank: 76

Insulin glargine: Uses, Interactions, Mechanism of Action - DrugBank
drugbank.com

https://go.drugbank.com/drugs/DB00047

Web504 rows · Insulin glargine is indicated to improve glycemic control in …

DA: 26 PA: 87 MOZ Rank: 53

Pharmacokinetics and pharmacodynamics of insulin …
nih.gov

https://pubmed.ncbi.nlm.nih.gov/25524950/

WebResearch design and methods: Ten T2DM insulin-treated persons were studied … Author: Francesca Porcellati, Paola Lucidi, Patrizia Cioli, Paola Candeloro, Anna Marinelli Andreoli, Stefan... Publish Year: 2015

Author: Francesca Porcellati, Paola Lucidi, Patrizia Cioli, Paola Candeloro, Anna Marinelli Andreoli, Stefan...
Publish Year: 2015

DA: 83 PA: 28 MOZ Rank: 17

Insulin – Pharmacology, Therapeutic Regimens, and …
nih.gov

https://www.ncbi.nlm.nih.gov/books/NBK278938/

WebFeb 23, 2019 · Insulin pharmacodynamics refers to the metabolic effect of insulin. Commercially available insulins are categorized as rapid-acting, … Author: Thomas Donner, Sudipa Sarkar Authors: Thomas Donner, Sudipa Sarkar Publish Year: 2015 Published: 2019/02/23

Author: Thomas Donner, Sudipa Sarkar
Authors: Thomas Donner, Sudipa Sarkar
Publish Year: 2015
Published: 2019/02/23

DA: 93 PA: 56 MOZ Rank: 78

Insulin Glargine: Package Insert / Prescribing Information
drugs.com

https://www.drugs.com/pro/insulin-glargine.html

WebMay 2, 2022 · Insulin Glargine U-300 is a long-acting man-made insulin used to control …

DA: 60 PA: 92 MOZ Rank: 81

Pharmacokinetics and Pharmacodynamics of Insulin …
diabetesjournals.org

https://diabetesjournals.org/care/article/38/3/503/37585/Pharmacokinetics-and-Pharmacodynamics-of-Insulin

WebDec 18, 2014 · After a 2-week run-in period, during which subjects with diabetes …

DA: 11 PA: 91 MOZ Rank: 86

Pharmacokinetics and pharmacodynamics of insulin …
nih.gov

https://pubmed.ncbi.nlm.nih.gov/27453980/

WebIntroduction: A more concentrated insulin glargine formulation, containing 300 U/mL …

DA: 68 PA: 76 MOZ Rank: 50

Pharmacokinetics and Pharmacodynamics of the Long …
diabetesjournals.org

https://diabetesjournals.org/care/article/30/5/1261/29895/Pharmacokinetics-and-Pharmacodynamics-of-the-Long

WebMay 1, 2007 · Pharmacokinetics and pharmacodynamics of the long-acting insulin …

DA: 41 PA: 47 MOZ Rank: 85

Pharmacokinetics, Pharmacodynamics, and Modulation of …
diabetesjournals.org

https://diabetesjournals.org/care/article/42/1/85/36308/Pharmacokinetics-Pharmacodynamics-and-Modulation

WebOct 10, 2018 · This study characterized the pharmacokinetics (PK), pharmacodynamics …

DA: 57 PA: 72 MOZ Rank: 42

NPH Insulin - StatPearls - NCBI Bookshelf
nih.gov

https://www.ncbi.nlm.nih.gov/books/NBK549860/

WebJun 21, 2022 · Recent clinical trials have shown that modern basal insulin analogs such as insulin glargine and insulin detemir have a lower risk of hypoglycemia and lower variability of fasting blood glucose compared to …

DA: 31 PA: 39 MOZ Rank: 18